Furthermore, BCL2, an oncogenic gene that plays an anti-apoptotic role in cancer and drives its progression41–44, demonstrated an incrementally enhanced regulatory score from normal B cells to BLS3 (Fig. 4i, Supplementary Data 16), lending further credibility to our inference. Here, BCL2 is linked to cancer.